Home / Biosimilars / News / EMA approval for pegfilgrastim biosimilar Grasustek

EMA approval for pegfilgrastim biosimilar Grasustek Posted 10/05/2019

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 26 April 2019 that it had recommended the granting of a marketing authorization for the pegfilgrastim biosimilar Grasustek.

Grasustek is a biosimilar of Amgen’s Neulasta (pegfilgrastim), which is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue filgrastim. Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils (white blood cells) to fight infection in patients undergoing chemotherapy. The patents on Neulasta expired in the US in October 2015 and expired in Europe in August 2017 [1].

Grasustek was developed by Indian biosimilars maker USV. The application for approval of the biosimilar was submitted to EMA in December 2017 by USV subsidiary Juta Pharma, a German-based generics maker that USV acquired in March 2018.

EMA’s approval for Grasustek was based on data from phase I and phase III studies carried out in Europe. The phase I study compared the pharmacokinetics and pharmacodynamics of the biosimilar with the originator biological Neulasta at both a therapeutic dose and a low dose. The phase III study followed 254 patients with breast cancer who were scheduled to undergo chemotherapy.

USV is also planning a phase I study in the US and has already held a pre-IND meeting with the US Food and Drug Administration. The company has also completed a phase III study in India.

EMA’s CHMP has recommended that Grasustek be approved for prophylaxis against neutropenia in adult patients treated with cytotoxic chemotherapy.

The CHMP’s opinion will now be reviewed by the European Commission (EC). There are already five pegfilgrastim biosimilars (Fulphila, Pelgraz, Pelmeg, Udenyca and Ziextenzo) approved in the European Union [2].

Related article
Biosimilars of pegfilgrastim

References
1. Derbyshire M. Patent expiry dates for biologicals: 2017 update. Generics and Biosimilars Initiativ Journal (GaBI Journal). 2018;7(1):29-34. doi:10.5639/gabij.2018.0701.007
2. GaBI Online - Generics and Biosimilars Initiative. Biosimilars approved in Europe [www.gabionline.net]. Mol, Belgium: Pro Pharma Communications International; [cited 2019 May 10]. Available from: www.gabionline.net/Biosimilars/General/Biosimilars-approved-in-Europe

Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Copyright – Unless otherwise stated all contents of this website are © 2019 Pro Pharma Communications International. All Rights Reserved.

Source: EMA, USV

Comments (1)

cure posted 22/09/2019 - by mary johnson

ALL THANKS TO DR OSO WITH HIS HERBAL PORTION I WAS COMPLETELY CURED FROM BREAST CANCER.  I'm here again to appreciate. DR OSO God will always continue to bless you more abundantly, for the good works you don in my life, I will always keep on writing good and posting my testimonies about you on the Internet, I’m MARY JOHNSON from TEXAS . I was tested breast cancer positive, I saw a blog on how DR OSO cured people with his herbal portion, i did not believe in natural medicine but i just decided to give him a try, I contacted him,and explain my situation to him,few day later he sent me the herb, after taking DR OSO  herbal medicine for few weeks i went to hospital for check up so luckily i was healed  with his herbal portion, i am so happy. If you have any type of cancer problem or you are also infected with any kind of disease, contact him drosohaberhome@gmail.com or call/whatapp +2348162084839 for advice and for his product,i hope this testimony also help some one out there ..              here is the  dr website. https://sites.google.com/view/drosohaberhome/ His blog page https://drosohaberhome.blogspot.com you can also email me for more info about DR oso  via maryjohnson9700@gmail.com     ALL THANK TO DR OSO .